News

Targeted Oncology49m
Five-Year Data Highlights Cilta-Cel’s Impact in Myeloma, Says Dr Voorhees
Peter M. Voorhees, MD, discusses the 5-year follow-up results from the CARTITUDE-1 trial of ciltacabtagene autoleucel for the ...